|
|
||||||||
University of Cambridge Neurology Unit (Drs. Mumford, Wood, and Compston, and H. Kellar-Wood), Addenbrooke's Hospital, Cambridge; and the Multiple Sclerosis NMR Research Group (Drs. Thorpe and Miller), Institute of Neurology, London, UK.
During a 27-month recruitment period, we identified 146 individuals with multiple sclerosis (MS) who have a twin. A single clinician interviewed and examined 105 pairs of twins, and we confirmed zygosity using minisatellite probes. Including two suspected cases, 11 of 44 (25%) monozygotic twin pairs were concordant compared with two of 61 (3%) dizygotic twin pairstwo of 33 (6%) like-sexed and zero of 28 (0%) opposite-sexed. MRI was performed in 64 of 105 co-twins, and showed abnormalities consistent with demyelination in 13% of monozygotic and 9% of dizygotic co-twins who were clinically unaffected. These findings are similar to the results of most previous studies of MS in twins in which zygosity was not unequivocally established and where the majority of clinically unaffected co-twins were not studied by MRI; the difference in concordance rates in monozygotic and dizygotic twins indicates a significant genetic component in the etiology of MS.
Address correspondence and reprint requests to Dr. D.A.S. Compston, University of Cambridge Neurology Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK.
Supported by the Multiple Sclerosis Society of Great Britain and Northern Ireland
Received April 14, 1993. Accepted for publication in final form June 25, 1993
This article has been cited by other articles:
![]() |
D. F. de Abreu, M. Babron I, C. Rebeix, J. Fontenille, D. Yaouanq, B. Brassat, F. Fontaine, F. Clerget-Darpoux, F. Jehan, and Feron Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis Multiple Sclerosis, October 1, 2009; 15(10): 1146 - 1152. [Abstract] [PDF] |
||||
![]() |
C. Hawkes and A. Macgregor Twin studies and the heritability of MS: a conclusion Multiple Sclerosis, June 1, 2009; 15(6): 661 - 667. [Abstract] [PDF] |
||||
![]() |
S. P. Kallio, E. Jakkula, S. Purcell, M. Suvela, K. Koivisto, P. J. Tienari, I. Elovaara, T. Pirttila, M. Reunanen, D. Bronnikov, et al. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS Hum. Mol. Genet., May 1, 2009; 18(9): 1670 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sawcer The complex genetics of multiple sclerosis: pitfalls and prospects Brain, December 1, 2008; 131(12): 3118 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuusisto, H. Hyoty, S. Kares, E. Kinnunen, and I. Elovaara Human herpes virus 6 and multiple sclerosis: a Finnish twin study Multiple Sclerosis, January 1, 2008; 14(1): 54 - 58. [Abstract] [PDF] |
||||
![]() |
S Haghighi, O Andersen, S Nilsson, L Rydberg, and J Wahlstrom A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy Multiple Sclerosis, November 1, 2006; 12(6): 723 - 730. [Abstract] [PDF] |
||||
![]() |
S. BLUMENTHAL Multiple sclerosis. Radiol. Technol., March 1, 2006; 77(4): 309 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Fujinami, M. G. von Herrath, U. Christen, and J. L. Whitton Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease Clin. Microbiol. Rev., January 1, 2006; 19(1): 80 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hohler, E. Reuss, P. Adams, B. Bartsch, B. Weigmann, M. Worns, P. R. Galle, A. Victor, and M. F. Neurath A Genetic Basis for IFN-{gamma} Production and T-bet Expression in Humans J. Immunol., October 15, 2005; 175(8): 5457 - 5462. [Abstract] [Full Text] [PDF] |
||||
![]() |
G C Ebers A twin consensus in MS Multiple Sclerosis, October 1, 2005; 11(5): 497 - 499. [PDF] |
||||
![]() |
T Hansen, A Skytthe, E Stenager, H C Petersen, H Bronnum-Hansen, and K O Kyvik Concordance for multiple sclerosis in Danish twins: an update of a nationwide study Multiple Sclerosis, October 1, 2005; 11(5): 504 - 510. [Abstract] [PDF] |
||||
![]() |
J Zajicek Diagnosis and disease modifying treatments in multiple sclerosis Postgrad. Med. J., September 1, 2005; 81(959): 556 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Dyment, A. D. Sadovnick, C. J. Willer, H. Armstrong, Z. M. Cader, S. Wiltshire, B. Kalman, N. Risch, and G. C. Ebers An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group Hum. Mol. Genet., May 15, 2004; 13(10): 1005 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santos, M. do Carmo Costa, M. E. Rio, M. J. Sa, M. Monteiro, A. Valenca, A. Sa, J. Dinis, J. Figueiredo, L. B. de Almeida, et al. Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin Multiple Sclerosis, April 1, 2004; 10(2): 153 - 157. [Abstract] [PDF] |
||||
![]() |
A. B. Oturai, L. P Ryder, S. Fredrikson, K.-M. Myhr, E. G Celius, H. F. Harbo, O. Andersen, E. ASkesson, J. Hillert, H. O Madsen, et al. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs Multiple Sclerosis, February 1, 2004; 10(1): 5 - 8. [Abstract] [PDF] |
||||
![]() |
C. J. Willer, D. A. Dyment, N. J. Risch, A. D. Sadovnick, and G. C. Ebers Twin concordance and sibling recurrence rates in multiple sclerosis PNAS, October 28, 2003; 100(22): 12877 - 12882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Bomprezzi, P E Kovanen, and R Martin New approaches to investigating heterogeneity in complex traits J. Med. Genet., August 1, 2003; 40(8): 553 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O'Connor Key issues in the diagnosis and treatment of multiple sclerosis: An overview Neurology, September 24, 2002; 59(90063): S1 - 33. [Full Text] |
||||
![]() |
J.-F. Bach The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases N. Engl. J. Med., September 19, 2002; 347(12): 911 - 920. [Full Text] [PDF] |
||||
![]() |
I McDonald Multiple sclerosis in its European matrix Multiple Sclerosis, June 1, 2002; 8(3): 181 - 191. [PDF] |
||||
![]() |
S. Sawcer, M. Maranian, E. Setakis, V. Curwen, E. Akesson, A. Hensiek, F. Coraddu, R. Roxburgh, D. Sawcer, J. Gray, et al. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility Brain, June 1, 2002; 125(6): 1337 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Marrosu, M. Lai, E. Cocco, V. Loi, G. Spinicci, M. P. Pischedda, S. Massole, G. Marrosu, and P. Contu Genetic factors and the founder effect explain familial MS in Sardinia Neurology, January 22, 2002; 58(2): 283 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Siger-Zajdel and K Selmaj Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(6): 752 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Chataway, A Mander, N Robertson, S Sawcer, J Deans, M Fraser, S Broadley, D Clayton, and A Compston Multiple sclerosis in sibling pairs: an analysis of 250 families J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(6): 757 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Johnson, R E Ferner, M Bobrow, and R A C Hughes Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 643 - 646. [Abstract] [Full Text] |
||||
![]() |
G. C. Ebers, W. J. Koopman, W. Hader, A. D. Sadovnick, M. Kremenchutzky, P. Mandalfino, D. M. Wingerchuk, J. Baskerville, and G. P. A. Rice The natural history of multiple sclerosis: a geographically based study: 8: Familial multiple sclerosis Brain, March 1, 2000; 123(3): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Smith, N. L. Eller, H. F. McFarland, M. K. Racke, and C. S. Raine Age Dependence of Clinical and Pathological Manifestations of Autoimmune Demyelination : Implications for Multiple Sclerosis Am. J. Pathol., October 1, 1999; 155(4): 1147 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Confavreux, S Vukusic, J Grimaud, and T Moreau Clinical progression and decision making process in multiple sclerosis Multiple Sclerosis, August 1, 1999; 5(4): 212 - 215. [PDF] |
||||
![]() |
D. Brassat, C. Azais-Vuillemin, J. Yaouanq, G. Semana, J. Reboul, I. Cournu, C. Mertens, G. Edan, O. Lyon-Caen, M. Clanet, et al. Familial factors influence disability in MS multiplex families Neurology, May 1, 1999; 52(8): 1632 - 1632. [Abstract] [Full Text] |
||||
![]() |
J. C Fulton, R. I Grossman, L. J Mannon, J. Udupa, and D. L Kolson Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals Multiple Sclerosis, April 1, 1999; 5(2): 74 - 77. [Abstract] [PDF] |
||||
![]() |
G. McDonnell and S. Hawkins Primary progressive multiple sclerosis: a distinct syndrome? Multiple Sclerosis, October 1, 1996; 2(3): 137 - 141. [Abstract] [PDF] |
||||
![]() |
Meeting Report and Proceedings: Multiple Sclerosis Society of Great Britain and Northern Ireland Multiple Sclerosis, August 1, 1996; 2(1): 1 - 55. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |